To further explore potential markers of prognosis, we analyzed 69 primary AMs for the compositions of various immune cells, including CD8+ T cells, M1 macrophages, M2 macrophages, CD56 bright NK cells, and CD56 dim NK cells both in the tumor center (TC) and the invasive margin (IM) by using mIHC. This evidence concerns the gene NCAM1 and neoplasm.